Association of Tdap Vaccination With Acute Events and Adverse Birth Outcomes Among Pregnant Women With Prior Tetanus-Containing Immunizations
- PMID: 26501534
- PMCID: PMC6586223
- DOI: 10.1001/jama.2015.12790
Association of Tdap Vaccination With Acute Events and Adverse Birth Outcomes Among Pregnant Women With Prior Tetanus-Containing Immunizations
Abstract
Importance: The Advisory Committee on Immunization Practices (ACIP) recommends the tetanus, diphtheria, and acellular pertussis (Tdap) vaccine for pregnant women during each pregnancy, regardless of prior immunization status. However, safety data on repeated Tdap vaccination in pregnancy is lacking.
Objective: To determine whether receipt of Tdap vaccine during pregnancy administered in close intervals from prior tetanus-containing vaccinations is associated with acute adverse events in mothers and adverse birth outcomes in neonates.
Design, setting, and participants: A retrospective cohort study in 29,155 pregnant women aged 14 through 49 years from January 1, 2007, through November 15, 2013, using data from 7 Vaccine Safety Datalink sites in California, Colorado, Minnesota, Oregon, Washington, and Wisconsin.
Exposures: Women who received Tdap in pregnancy following a prior tetanus-containing vaccine less than 2 years before, 2 to 5 years before, and more than 5 years before.
Main outcomes and measures: Acute adverse events (fever, allergy, and local reactions) and adverse birth outcomes (small for gestational age, preterm delivery, and low birth weight) were evaluated. Women who were vaccinated with Tdap in pregnancy and had a prior tetanus-containing vaccine more than 5 years before served as controls.
Results: There were no statistically significant differences in rates of medically attended acute adverse events or adverse birth outcomes related to timing since prior tetanus-containing vaccination. [table: see text].
Conclusions and relevance: Among women who received Tdap vaccination during pregnancy, there was no increased risk of acute adverse events or adverse birth outcomes for those who had been previously vaccinated less than 2 years before or 2 to 5 years before compared with those who had been vaccinated more than 5 years before. These findings suggest that relatively recent receipt of a prior tetanus-containing vaccination does not increase risk after Tdap vaccination in pregnancy.
Conflict of interest statement
Figures
![Figure.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/6586223/bin/nihms-1025410-f0001.gif)
Comment in
-
Repeat Tdap Vaccination and Adverse Birth Outcomes.JAMA. 2016 Mar 22-29;315(12):1285-6. doi: 10.1001/jama.2015.19078. JAMA. 2016. PMID: 27002454 No abstract available.
-
Repeat Tdap Vaccination and Adverse Birth Outcomes--Reply.JAMA. 2016 Mar 22-29;315(12):1286. doi: 10.1001/jama.2015.19087. JAMA. 2016. PMID: 27002457 Free PMC article. No abstract available.
Similar articles
-
Factors associated with Tdap vaccination receipt during pregnancy: a cross-sectional study.Public Health. 2020 Feb;179:38-44. doi: 10.1016/j.puhe.2019.10.001. Epub 2019 Nov 11. Public Health. 2020. PMID: 31726399 Review.
-
Tetanus, diphtheria, and acellular pertussis vaccination during pregnancy and reduced risk of infant acute respiratory infections.Vaccine. 2017 Oct 9;35(42):5603-5610. doi: 10.1016/j.vaccine.2017.08.041. Epub 2017 Sep 12. Vaccine. 2017. PMID: 28916245
-
Safety of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis and Influenza Vaccinations in Pregnancy.Obstet Gynecol. 2015 Nov;126(5):1069-1074. doi: 10.1097/AOG.0000000000001066. Obstet Gynecol. 2015. PMID: 26444109 Free PMC article.
-
Evaluation of the association of maternal pertussis vaccination with obstetric events and birth outcomes.JAMA. 2014 Nov 12;312(18):1897-904. doi: 10.1001/jama.2014.14825. JAMA. 2014. PMID: 25387187 Free PMC article.
-
Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm Rep. 2008 May 30;57(RR-4):1-51. MMWR Recomm Rep. 2008. PMID: 18509304 Review.
Cited by
-
Prenatal Maternal Immunization for Infant Protection: A Review of the Vaccines Recommended, Infant Immunity and Future Research Directions.Pathogens. 2024 Feb 23;13(3):200. doi: 10.3390/pathogens13030200. Pathogens. 2024. PMID: 38535543 Free PMC article. Review.
-
Defining and reporting adverse events of special interest in comparative maternal vaccine studies: a systematic review.Vaccine X. 2024 Feb 23;18:100464. doi: 10.1016/j.jvacx.2024.100464. eCollection 2024 Jun. Vaccine X. 2024. PMID: 38495929 Free PMC article. Review.
-
Immunogenicity at delivery after Tdap vaccination in successive pregnancies.Front Immunol. 2024 Feb 23;15:1360201. doi: 10.3389/fimmu.2024.1360201. eCollection 2024. Front Immunol. 2024. PMID: 38464513 Free PMC article.
-
Safety and Clinical Benefits of Adacel® and Adacel®-Polio Vaccination in Pregnancy: A Structured Literature Review.Infect Dis Ther. 2023 Aug;12(8):1955-2003. doi: 10.1007/s40121-023-00847-5. Epub 2023 Sep 1. Infect Dis Ther. 2023. PMID: 37653123 Free PMC article. Review.
-
Protecting the Offspring, the Gift of Maternal Immunization: Current Status and Future Perspectives.Vaccines (Basel). 2022 Nov 18;10(11):1953. doi: 10.3390/vaccines10111953. Vaccines (Basel). 2022. PMID: 36423047 Free PMC article. Review.
References
-
- Cherry JD. Epidemic pertussis in 2012—the resurgence of a vaccine-preventable disease. N Engl J Med. 2012;367(9):785–787. - PubMed
-
- Centers of Disease Control and Prevention. Pertussis outbreak trends. http://www.cdc.gov/pertussis/outbreaks/trends.html. Accessed May 20, 2015.
-
- Murphy TV, Slade BA, Broder KR, et al. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57(RR-4):1–51. - PubMed
-
- Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months—Advisory Committee on Immunization Practices(ACIP),2011.MMWR Morb Mortal Wkly Rep. 2011;60(41):1424–1426. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical